Healthcare Services

One of the Major Drivers of the Endometriosis Market Is the Elevated Ovarian Cancer Incidence Fuels Growth In The Endometriosis Market

April 1, 2026April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Endometriosis Market Across 2026–2030?

The endometriosis market has shown strong growth in recent years. It is anticipated to expand from $1.54 billion in 2025 to $1.68 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.0%. The expansion observed in the historic period is linked to the underdiagnosis of endometriosis, an increase in gynecological consultations, a rise in infertility cases, the adoption of hormonal therapy, and the demand for pain management.

The market for endometriosis is projected to experience substantial expansion in the upcoming years. This market is anticipated to reach a valuation of $2.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.8%. The projected growth during this period stems from factors such as early screening efforts, enhanced diagnostic precision, tailored treatment methods, greater advocacy for women’s health, and an increase in specialized care services. Key developments anticipated within the forecast timeframe involve heightened awareness regarding chronic pelvic pain, a rise in the diagnosis of fertility-related conditions, wider adoption of hormonal therapies, the establishment of more specialty gynecology centers, and an emphasis on sustained disease management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13035&type=smp

What Primary Drivers Are Shaping The Development Of The Endometriosis Market?

The rising occurrence of ovarian cancer is anticipated to drive expansion in the endometriosis market. Ovarian cancer begins in the ovaries, female reproductive organs essential for producing eggs and the hormones estrogen and progesterone. Endometriosis is linked to an elevated risk of developing epithelial ovarian cancer, predominantly the endometrioid and precise cell cancer subtypes, characterized by high estrogen concentrations that can heighten the risk of ovarian cancer. For example, in January 2023, the American Cancer Society, a US-based professional organization, projected approximately 19,710 new cases of ovarian cancer would be diagnosed among women in the US that year. Furthermore, the Ovarian Cancer Research Alliance, a US-based not-for-profit organization, stated that ovarian cancer led to 12,810 deaths in 2022, increasing to 13,270 fatalities in 2023. This increasing incidence of ovarian cancer is thus propelling the growth of the endometriosis market.

What Segmentation Levels Are Considered In The Endometriosis Market?

The endometriosis market covered in this report is segmented –

1) By Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types

2) By Treatment Type: Hormonal Therapy, Pain Management

3) By Drug: Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs

4) By End-User: Hospitals, Homecare, Specialty Centers, Other End-Users

Subsegments:

1) By Superficial Peritoneal Lesion: Minimal Lesions, Mild Lesions, Peritoneal Surface Lesions

2) By Endometrioma: Ovarian Endometrioma, Chocolate Cyst, Bilateral Endometrioma

3) By Deeply Infiltrating Endometriosis: Rectovaginal Deep Lesions, Bladder Deep Lesions, Ureteral Deep Lesions

4) By Other Types: Adenomyosis-Associated Endometriosis, Extraperitoneal Endometriosis, Rare Anatomical Site Endometriosis

How Are Trends Impacting The Endometriosis Market?

Leading companies in the endometriosis market are developing advanced solutions, including non-invasive diagnostic assays, to enhance early detection and patient management. Non-invasive diagnostic assays are tests designed to identify or monitor a disease without the need for surgery or instrument insertion into the body, frequently utilizing substances like blood, urine, saliva, or imaging. For example, in July 2025, Kephera Diagnostics LLC, a US-based diagnostic laboratory, introduced EndomTest, a novel blood-based diagnostic test for endometriosis. EndomTest is a laboratory-developed test that examines a patient’s serum sample for the biomarkers Brain-Derived Neurotrophic Factor (BDNF) and Cancer Antigen 125 (CA125). It then integrates these biomarker outcomes with chosen clinical variables using a proprietary diagnostic algorithm to produce a positive or negative “rule-in” indication for endometriosis. Its key characteristics include a non-surgical sampling approach (simply a blood draw), high specificity (reported at nearly 100%) for disease identification, and clinical relevance for women presenting with pelvic pain, heavy menstrual bleeding, infertility, or pain during sexual intercourse.

Which Leading Firms Are Contributing To The Growth Of The Endometriosis Market?

Major companies operating in the endometriosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck and Co. Inc., Abbvie Inc., Bayer AG, GlaxoSmithKline plc, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Gedeon Richter plc, Torrent Pharmaceuticals Ltd., Ferring Pharmaceuticals, Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., Repros Therapeutics Inc., Myovant Sciences Ltd., Takeda Pharmaceutical Company Limited, ObsEva SA, Gesynta Pharma AB, Zydus Healthcare Limited

Read the full endometriosis market report here:

https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report

How Does The Endometriosis Market Perform Across Major Global Regions?

North America was the largest region in the endometriosis market in 2025. The regions covered in the endometriosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Endometriosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13035&type=smp

Browse Through More Reports Similar to the Global Endometriosis Market 2026, By The Business Research Company

Cosmetic Surgery Global Market Report

https://www.thebusinessresearchcompany.com/report/cosmetic-surgery-global-market-report

Orthotics Global Market Report

https://www.thebusinessresearchcompany.com/report/orthotics-global-market-report

Digital Dentistry Global Market Report

https://www.thebusinessresearchcompany.com/report/digital-dentistry-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795